Cargando…
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
Despite effective treatments, cytomegalovirus (CMV) continues to have a significant impact on morbidity and mortality in allogeneic stem cell transplant (allo-SCT) recipients. This multicenter, retrospective, cohort study aimed to evaluate the reproducibility of the safety and efficacy of commercial...
Ejemplares similares
-
Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
por: Martino, Massimo, et al.
Publicado: (2020) -
How I Manage Chronic Lymphocytic Leukemia
por: Nasnas, Patrice, et al.
Publicado: (2023) -
Measures of frequency and effect in clinical research
por: D’Arrigo, Graziella, et al.
Publicado: (2023) -
Letermovir for cytomegalovirus prophylaxis
Publicado: (2019) -
Use of letermovir in umbilical cord blood transplantation based on risk scores
por: Rivera Franco, Monica M., et al.
Publicado: (2023)